Evozyne

Evozyne is an AI-native protein therapeutics company founded in 2020 by Paragon Biosciences and headquartered in Chicago, Illinois. It combines generative machine learning with directed evolution and high-throughput biology to design de novo proteins — which it brands Natural Machines — and advance them as engineered protein therapeutics for immune-mediated diseases. The platform pairs AI protein design with wet-lab build-and-test cycles, and the company has collaborated with NVIDIA on model work and with the Gates Foundation on sustainability applications. Evozyne is a drug-discovery organization rather than a software vendor: it publishes a corporate website, a pipeline page, scientific publications and news, but no public API, developer portal, SDK or machine-readable specification of any kind.

Evozyne is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Artificial Intelligence, and Protein Design.

Evozyne’s developer surface includes product news and 11 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyLife SciencesArtificial IntelligenceProtein DesignDrug DiscoveryTherapeuticsImmunologyMachine Learning

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 11.7/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.6 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/evozyne: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Evozyne Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Build 1

SDKs, sample code, and the tooling you integrate with

GitHubOrganization
GitHubOrganization

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact
Contact

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService
TermsOfService
 PrivacyPolicy
PrivacyPolicy

Company 4

The organization behind the API

Website
Website
 News
News
 Careers
Careers
 About
About

Other 2

Properties that don't map to a standard resource type

Products
Products
 Research
Research

Source (apis.yml)

apis.yml Raw ↑ 
aid: evozyne
name: Evozyne
description: 'Evozyne is an AI-native protein therapeutics company founded in 2020 by Paragon Biosciences and headquartered
  in Chicago, Illinois. It combines generative machine learning with directed evolution and high-throughput biology to design
  de novo proteins — which it brands Natural Machines — and advance them as engineered protein therapeutics for immune-mediated
  diseases. The platform pairs AI protein design with wet-lab build-and-test cycles, and the company has collaborated with
  NVIDIA on model work and with the Gates Foundation on sustainability applications. Evozyne is a drug-discovery organization
  rather than a software vendor: it publishes a corporate website, a pipeline page, scientific publications and news, but
  no public API, developer portal, SDK or machine-readable specification of any kind.'
url: https://raw.githubusercontent.com/api-evangelist/evozyne/refs/heads/main/apis.yml
image: https://evozyne.com/wp-content/themes/evozyne/markup/dist/images/logo.svg
x-type: company
x-source: harvest:secondary-market
x-source-url: https://forgeglobal.com/evozyne_stock/
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-12'
modified: '2026-08-12'
tags:
- Company
- Biotechnology
- Life Sciences
- Artificial Intelligence
- Protein Design
- Drug Discovery
- Therapeutics
- Immunology
- Machine Learning
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/evozyne-domain-security.yml
- type: Website
  url: https://evozyne.com/
- type: GitHubOrganization
  url: https://github.com/Evozyne
- type: TermsOfService
  url: https://evozyne.com/terms-of-use/
- type: PrivacyPolicy
  url: https://evozyne.com/privacy-policy/
- type: News
  url: https://evozyne.com/about-us/news/
- type: Careers
  url: https://evozyne.com/careers/
- type: Contact
  url: https://evozyne.com/contact-us/
- type: Products
  url: https://evozyne.com/platform/
- type: Research
  url: https://evozyne.com/platform/science/
- type: About
  url: https://evozyne.com/about-us/
- type: LLMsTxt
  url: llms/evozyne-llms.txt
x-enrichment:
  date: '2026-08-12'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Evozyne is a clinical-stage protein therapeutics company whose product is a drug pipeline rather than software,
    and evozyne.com is a WordPress marketing site where /openapi.json, /graphql and every /.well-known/ path 404 while api.,
    docs. and developer.evozyne.com do not resolve in DNS at all.
  evidence:
  - url: https://evozyne.com/openapi.json
    status: 404
  - url: https://evozyne.com/graphql
    status: 404
  - url: https://evozyne.com/.well-known/agent-card.json
    status: 404
  - url: https://evozyne.com/llms.txt
    status: 404
  - url: https://evozyne.com/
    status: 200
  checked: '2026-08-12'